September 9, 2019– Congress is back in town this week after the end of its August recess, and lawmakers are gearing up for a busy fall with a major focus on how to slow down ever-increasing drug prices. The cost of prescription drugs is on the minds of members from both parties in Congress as well as members of the Trump administration. Before they left town, two Senate … [Read more...]
House Panel Issues 340B Report; 340B Health Both Appreciative and Concerned
January 10, 2018—The full House Energy & Commerce Committee released a report this afternoon calling on Congress to clarify the 340B program’s intent, give the Health Resources and Services Administration (HRSA) more regulatory authority over the program, increase reporting requirements for hospitals, and revise hospital eligibility requirements. 340B Health, which … [Read more...]
More Than Half of U.S. House Urges CMS to Drop 340B Hospital Cuts
September 29, 2017—A bipartisan majority of the U.S. House of Representatives wants the Trump administration to drop plans to slash what Medicare pays safety-net and rural hospitals for typically expensive specialty drugs that must be administered by trained professionals. The 228 Republican and Democratic lawmakers made the request in a Sept. 28 letter to Centers for … [Read more...]